174 related articles for article (PubMed ID: 30079703)
1. Investigation of Gene Expressions of Myeloma Cells in the Bone Marrow of Multiple Myeloma Patients by Transcriptome Analysis.
Sarıman M; Abacı N; Sırma Ekmekçi S; Çakiris A; Perçin Paçal F; Üstek D; Ayer M; Yenerel MN; Beşışık S; Çefle K; Palandüz Ş; Öztürk Ş
Balkan Med J; 2019 Jan; 36(1):23-31. PubMed ID: 30079703
[TBL] [Abstract][Full Text] [Related]
2. Identification of malignant cells in multiple myeloma bone marrow with immunoglobulin VH gene probes by fluorescent in situ hybridization and flow cytometry.
Cao J; Vescio RA; Hong CH; Kim A; Lichtenstein AK; Berenson JR
J Clin Invest; 1995 Mar; 95(3):964-72. PubMed ID: 7883997
[TBL] [Abstract][Full Text] [Related]
3. The Pattern of Mesenchymal Stem Cell Expression Is an Independent Marker of Outcome in Multiple Myeloma.
Schinke C; Qu P; Mehdi SJ; Hoering A; Epstein J; Johnson SK; van Rhee F; Zangari M; Thanendrarajan S; Barlogie B; Davies FE; Yaccoby S; Morgan GJ
Clin Cancer Res; 2018 Jun; 24(12):2913-2919. PubMed ID: 29563136
[No Abstract] [Full Text] [Related]
4. Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.
Colombo M; Galletti S; Bulfamante G; Falleni M; Tosi D; Todoerti K; Lazzari E; Crews LA; Jamieson CH; Ravaioli S; Baccianti F; Garavelli S; Platonova N; Neri A; Chiaramonte R
Oncotarget; 2016 Aug; 7(35):56013-56029. PubMed ID: 27463014
[TBL] [Abstract][Full Text] [Related]
5. Molecular signatures of multiple myeloma progression through single cell RNA-Seq.
Jang JS; Li Y; Mitra AK; Bi L; Abyzov A; van Wijnen AJ; Baughn LB; Van Ness B; Rajkumar V; Kumar S; Jen J
Blood Cancer J; 2019 Jan; 9(1):2. PubMed ID: 30607001
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel fusion transcripts in multiple myeloma.
Lin M; Lee PL; Chiu L; Chua C; Ban KHK; Lin AHF; Chan ZL; Chung TH; Yan B; Chng WJ
J Clin Pathol; 2018 Aug; 71(8):708-712. PubMed ID: 29453220
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma.
Ria R; Todoerti K; Berardi S; Coluccia AM; De Luisi A; Mattioli M; Ronchetti D; Morabito F; Guarini A; Petrucci MT; Dammacco F; Ribatti D; Neri A; Vacca A
Clin Cancer Res; 2009 Sep; 15(17):5369-78. PubMed ID: 19690192
[TBL] [Abstract][Full Text] [Related]
9. Mining the Plasma Cell Transcriptome for Novel Cell Surface Proteins.
Trezise S; Karnowski A; Fedele PL; Mithraprabhu S; Liao Y; D'Costa K; Kueh AJ; Hardy MP; Owczarek CM; Herold MJ; Spencer A; Shi W; Willis SN; Nutt SL; Corcoran LM
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042348
[TBL] [Abstract][Full Text] [Related]
10. Feasibility study: phosphospecific flow cytometry enabling rapid functional analysis of bone marrow samples from patients with multiple myeloma.
Simard C; Cloutier M; Néron S
Cytometry B Clin Cytom; 2014 Mar; 86(2):139-44. PubMed ID: 24243860
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin gene rearrangement in multiple myeloma: limitations of Southern blot analysis.
Humphries JE; Dressman HK; Williams ME
Hum Pathol; 1991 Oct; 22(10):966-71. PubMed ID: 1842385
[TBL] [Abstract][Full Text] [Related]
12. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
[TBL] [Abstract][Full Text] [Related]
13. FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma.
Zhang W; Wu C; Geng S; Wang J; Yan C; Zhang X; Zhang JJ; Wu F; Pang Y; Zhong Y; Wang J; Fu W; Huang X; Wang W; Lyu X; Huang Y; Jing H
Aging (Albany NY); 2023 May; 15(9):3644-3677. PubMed ID: 37155154
[TBL] [Abstract][Full Text] [Related]
14.
Bolzoni M; Ronchetti D; Storti P; Donofrio G; Marchica V; Costa F; Agnelli L; Toscani D; Vescovini R; Todoerti K; Bonomini S; Sammarelli G; Vecchi A; Guasco D; Accardi F; Palma BD; Gamberi B; Ferrari C; Neri A; Aversa F; Giuliani N
Haematologica; 2017 Apr; 102(4):773-784. PubMed ID: 28057743
[TBL] [Abstract][Full Text] [Related]
15. Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma.
Ronchetti D; Agnelli L; Taiana E; Galletti S; Manzoni M; Todoerti K; Musto P; Strozzi F; Neri A
Oncotarget; 2016 Mar; 7(12):14814-30. PubMed ID: 26895470
[TBL] [Abstract][Full Text] [Related]
16. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
Billadeau D; Ahmann G; Greipp P; Van Ness B
J Exp Med; 1993 Sep; 178(3):1023-31. PubMed ID: 8350044
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment.
Klein B; Seckinger A; Moehler T; Hose D
Recent Results Cancer Res; 2011; 183():39-86. PubMed ID: 21509680
[TBL] [Abstract][Full Text] [Related]
18. Role of interleukin 16 in multiple myeloma.
Atanackovic D; Hildebrandt Y; Templin J; Cao Y; Keller C; Panse J; Meyer S; Reinhard H; Bartels K; Lajmi N; Sezer O; Zander AR; Marx AH; Uhlig R; Zustin J; Bokemeyer C; Kröger N
J Natl Cancer Inst; 2012 Jul; 104(13):1005-20. PubMed ID: 22745469
[TBL] [Abstract][Full Text] [Related]
19. Input of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applications.
Mahtouk K; Hose D; De Vos J; Moreaux J; Jourdan M; Rossi JF; Rème T; Goldschmidt H; Klein B
Clin Cancer Res; 2007 Dec; 13(24):7289-95. PubMed ID: 18094409
[TBL] [Abstract][Full Text] [Related]
20. Evidence of prolactin immunoreactivity in the bone marrow of untreated multiple myeloma patients.
Gadó K; Nagy G; Hasitz A; Tóth BE; Rimanóczi E; Domján G
Neuroimmunomodulation; 2001; 9(2):95-102. PubMed ID: 11549891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
